Search results
Showing 166 to 180 of 1002 results for public health medicine & health
Find out more about NICE technology appraisals advisory committee D members
Generalised anxiety disorder and panic disorder in adults: management (CG113)
This guideline covers the care and treatment of people aged 18 and over with generalised anxiety disorder (chronic anxiety) or panic disorder (with or without agoraphobia or panic attacks). It aims to help people achieve complete relief of symptoms (remission), which is associated with better functioning and a lower likelihood of relapse.
In development Reference number: GID-TA10143 Expected publication date: TBC
In development Reference number: GID-TA11186 Expected publication date: TBC
In development Reference number: GID-TA11636 Expected publication date: 26 August 2026
Unintentional injuries in the home: interventions for under 15s (PH30)
This guideline covers home safety assessments, supplying and installing safety equipment and providing education and advice. It aims to prevent unintentional injuries among all children and young people aged under 15 but, in particular, those living in disadvantaged circumstances.
View recommendations for PH30Show all sections
Sections for PH30
- Overview
- Recommendations
- Public health need and practice
- Considerations
- Recommendations for research
- References
- Appendix A: Membership of the Public Health Interventions Advisory Committee (PHIAC), the NICE project team and external contractors
- Appendix B: Summary of the methods used to develop this guidance
In development Reference number: GID-TA11649 Expected publication date: 14 October 2026
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
In development Reference number: GID-TA11096 Expected publication date: 03 September 2026
In development Reference number: GID-TA11635 Expected publication date: 26 August 2026
In development Reference number: GID-HST10067 Expected publication date: 14 October 2026
This guideline covers the short-term management of violence and aggression in adults (aged 18 and over), young people (aged 13 to 17) and children (aged 12 and under). It is relevant for mental health, health and community settings. The guideline aims to safeguard both staff and people who use services by helping to prevent violent situations and providing guidance to manage them safely when they occur.
This guideline covers diagnosing and managing myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) in children, young people and adults. It aims to improve awareness and understanding about ME/CFS and when to suspect it, so that people are diagnosed earlier. It includes recommendations on diagnosis, assessment and care planning, safeguarding, access to care and managing ME/CFS and its symptoms.
Biographies for all current members of the diagnostics advisory committee.
In development Reference number: GID-TA11545 Expected publication date: TBC
a rapid assessment of flu product zanamivir. First public board meeting Register to attend a public board meeting . 2000...